featured
Liraglutide Reduces Cardiac Adipose Tissue in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Liraglutide Reduces Cardiac Adipose Tissue in Type 2 Diabetes: A Secondary Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial
Diabetes Obes Metab 2021 Aug 13;[EPub Ahead of Print], IKB Rasmussen, EH Zobel, RS Ripa, BJ von Scholten, VR Curovic, JK Jensen, A Kjaer, TW Hansen, P RossingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.